Journal Information

Statistics

Follow this link to access the full text of the article

Original Article

A novel Autologous Cytokine-Rich Serum (SARC) to treat knee osteoarthritis patients’ refractory to a previous glucocorticoid intra-articular injection. A pilot study

Un nuevo suero autólogo rico en citoquinas (SARC) para el tratamiento de la artrosis de rodilla refractaria a infiltración intraarticular de glucocorticoides. Estudio piloto

Cristóbal Orellanaa, Silvia Garcia Cireraa, Albert Rodrigo Parésa, Laia Uriel Brotonsb, Àlex Arqué Corredorb, Cristina Aymericha, Rafael Gómeza, Anna Carrerasa, Antoni Berenguer-Llergoa, Joan Calveta,

Corresponding author

jcalvet@tauli.cat

Corresponding author.

a Department of Rheumatology, Parc Taulí Hospital Universitari, Institut d’Investigació i Innovació Parc Taulí (I3PT-CERCA), Universitat Autònoma de Barcelona, Sabadell, Spain

b Tecnologia Regenerativa Qrem S.L., Sant Pere d’Abanto, 4, 08014 Barcelona, Spain

Read

626

Times
was read the article

Total PDF

626

Total HTML

Share statistics

Article information

ISSN: 21735743
Original language: English

DOI:10.1016/j.reumae.2025.502016

The statistics are updated each day

Year/Month	Html	Pdf	Total
2026 1	239	0	239
2025 12	387	0	387

Follow this link to access the full text of the article

Statistics

Subscribe to our newsletter